784193-14-2 Usage
Molecular weight
214.19 g/mol This is the mass of a single molecule of 1-Propanol,2,2-difluoro-,benzoate(9CI), measured in grams per mole.
Physical state
Liquid This indicates that 1-Propanol,2,2-difluoro-,benzoate(9CI) is a liquid at room temperature and pressure.
Solubility
Insoluble in water This indicates that 1-Propanol,2,2-difluoro-,benzoate(9CI) does not dissolve well in water.
Boiling point
214-216°C This is the temperature at which 1-Propanol,2,2-difluoro-,benzoate(9CI) changes from a liquid to a gas.
Melting point
Not available This indicates that 1-Propanol,2,2-difluoro-,benzoate(9CI) does not have a well-defined melting point, which may be due to its relatively low molecular weight and the presence of fluorine atoms.
Uses
Solvent, intermediate in chemical processes, pharmaceutical and agrochemical industries, manufacturing of consumer products This lists some of the common uses of 1-Propanol,2,2-difluoro-,benzoate(9CI), including as a solvent in various chemical processes and as an intermediate in the production of other chemicals, as well as in the pharmaceutical and agrochemical industries and in the manufacturing of various consumer products.
Handling precautions
Potential health and environmental risks This indicates that 1-Propanol,2,2-difluoro-,benzoate(9CI) may pose health and environmental risks if not properly managed and disposed of, and should be handled with caution.
Check Digit Verification of cas no
The CAS Registry Mumber 784193-14-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,4,1,9 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 784193-14:
(8*7)+(7*8)+(6*4)+(5*1)+(4*9)+(3*3)+(2*1)+(1*4)=192
192 % 10 = 2
So 784193-14-2 is a valid CAS Registry Number.
784193-14-2Relevant articles and documents
NOVEL INHIBITORS
-
Page/Page column 69; 125, (2014/09/29)
The invention relates to a compound of formula (I) or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof, wherein R1, R2, R3, R4 and R5 are as defined herein, as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N- terminal glutamine residues into pyroglutamic acid (5-oxo-prolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water.
New bicyclic cannabinoid receptor-1 (CB1-R) antagonists
Carpino, Philip A.,Griffith, David A.,Sakya, Subas,Dow, Robert L.,Black, Shawn C.,Hadcock, John R.,Iredale, Philip A.,Scott, Dennis O.,Fichtner, Michael W.,Rose, Colin R.,Day, Robert,Dibrino, Joseph,Butler, Mary,DeBartolo, Demetria B.,Dutcher, Darrin,Gautreau, Denise,Lizano, Jeff S.,O'Connor, Rebecca E.,Sands, Michelle A.,Kelly-Sullivan, Dawn,Ward, Karen M.
, p. 731 - 736 (2007/10/03)
A series of conformationally constrained bicyclic derivatives derived from SR141716 was prepared and evaluated as hCB1-R antagonists and inverse agonists. Optimization of the structure-activity relationships around the 2,6-dihydro-pyrazolo[4,3-
Cannabinoid receptor ligands and uses thereof
-
Page 19, (2010/02/09)
Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
CANNABINOID RECEPTOR LIGANDS AND USES THEREOF
-
Page 33, (2010/02/09)
Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein.
